Nuvei Corporation (NVEI.CA) Forecast, Price Target & Analyst Ratings
TSX:NVEI • CA67079A1021
47.61 CAD
-0.26 (-0.54%)
Last: Nov 18, 2024, 07:00 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for Nuvei Corporation (NVEI.CA).
Forecast Snapshot
Consensus Price Target
CA$33.79
-29.03% Downside
Next Earnings Forecast
Release DateN/A
PeriodQ4 / 2024
EPS Estimate$0.57
Revenue Estimate376.73M
ChartMill Buy Consensus
71.43%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
CA$33.79
Upside
-29.03%
From current price of CA$47.61 to mean target of CA$33.79, Based on 14 analyst forecasts
Low
CA$29.29
Median
CA$34.68
High
CA$36.37
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
14 Wall Street analysts provided a forecast for the next 12 months for NVEI.CA. The average price target is 33.79 CAD. This implies a price decrease of -29.03% is expected in the next year compared to the current price of 47.61.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
71.43%
NVEI.CA was analyzed by 14 analysts. The buy percentage consensus is at 71. So analysts seem to be have mildly positive about NVEI.CA.
In the previous month the buy percentage consensus was at a similar level.
NVEI.CA was analyzed by 14 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2023-06-06 | WILLIAM BLAIR & COMPANY | Maintains | Outperform -> Outperform |
| 2022-11-01 | Scotiabank Capital | Maintains | Outperform |
| 2022-10-07 | Wolfe Research | Initiate | Buy |
| 2022-08-10 | Raymond James Capital | Downgrade | Outperform |
| 2022-08-10 | RBC Royalbank | Downgrade | Outperform |
| 2022-08-10 | National Bank of Canada Financial | Downgrade | Outperform |
| 2022-07-22 | Credit Suisse | Downgrade | Neutral |
| 2022-07-21 | National Bank of Canada Financial | Downgrade | Outperform |
| 2022-07-14 | Goldman Sachs | Downgrade | Hold |
| 2022-05-11 | RBC Royalbank | Downgrade | Outperform |
| 2022-05-11 | Canaccord Capital | Downgrade | Buy |
| 2022-05-11 | Cowen | Downgrade | Buy |
| 2022-03-29 | JP Morgan & Company | Upgrade | Overweight |
| 2022-03-29 | Sumitomo Mitsui Financial Group | Upgrade | Hold |
| 2022-03-09 | RBC Royalbank | Downgrade | Outperform |
| 2022-03-09 | Scotiabank Capital | Maintains | Outperform |
| 2022-01-31 | Sumitomo Mitsui Financial Group | Initiate | Hold |
| 2022-01-25 | Canaccord Capital | Initiate | Buy |
| 2022-01-21 | Cowen | Downgrade | Buy |
| 2021-12-10 | ScotiaBankFinancial | Maintains | Outperform |
| 2021-11-11 | RaymondJamesFinancials | Maintains | Outperform |
| 2021-11-10 | RaymondJamesFinancial | Upgrade | |
| 2021-11-10 | ScotiaBankFinancial | Upgrade | Outperform |
| 2021-10-13 | National Bank Financial | Initiate | Outperform |
| 2021-09-29 | Canaccord Genuity | Maintains | Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateN/A
PeriodQ4 / 2024
EPS Estimate$0.57
Revenue Estimate376.73M
Revenue Q2Q18.32%
EPS Q2Q20.23%
Number of Analysts6
Next Earnings Revisions
Revenue (1 Month)
0.19%
Revenue (3 Months)
0.51%
EPS (1 Month)
-1.44%
EPS (3 Months)
-2.52%
Next Earnings Summary
The next earnings revenue estimate has been revised upward by 0.51% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 724.526M 93.21% | 843.323M 16.40% | 1.19B 41.10% | 1.414B 18.83% | 1.635B 15.63% | 1.904B 16.45% | 2.129B 11.82% | |
| EBITDA YoY % growth | 238.958M 60.41% | 182.281M -23.72% | 309.701M 69.90% | 504.53M 62.91% | 605.02M 19.92% | 716.73M 18.46% | N/A | |
| EBIT YoY % growth | 148.13M 86.80% | 80.789M -45.46% | 173.278M 114.48% | 194.26M 12.11% | 269.03M 38.49% | 446.86M 66.10% | N/A | |
| Operating Margin | 20.45% | 9.58% | 14.56% | 13.74% | 16.45% | 23.47% | N/A | |
| EPS YoY % growth | 1.68 879.75% | 1.87 11.31% | 1.69 -9.63% | 1.98 16.94% | 2.56 29.59% | 3.30 28.66% | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.57 20.23% | 0.62 51.76% | 0.66 61.71% | 0.70 107.00% | 0.80 40.79% |
| Revenue Q2Q % growth | 376.73M 18.32% | 392.06M 16.99% | 398.41M 15.32% | 400.25M 11.92% | 438.55M 16.41% |
| EBITDA Q2Q % growth | 142.08M -26.68% | 144.84M 83.53% | 148.94M 18.31% | 152.12M 20.36% | 167.32M 17.76% |
| EBIT Q2Q % growth | 97.064M 69.22% | 68.442M 62.62% | 77.01M 50.85% | 83.538M 16.40% | 98.022M 0.99% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
24.93%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
16.28%
Revenue Next 5 Year
15.15%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
86.76%
EBIT Next 5 Year
N/A
Nuvei Corporation / NVEI.CA Forecast FAQ
What do analysts expect the price target to be for Nuvei Corporation (NVEI.CA)?
14 analysts have analysed NVEI.CA and the average price target is 33.79 CAD. This implies a price decrease of -29.03% is expected in the next year compared to the current price of 47.61.
Can you provide the consensus estimates for Nuvei Corporation next earnings?
The consensus EPS estimate for the next earnings of Nuvei Corporation (NVEI.CA) is 0.57 CAD and the consensus revenue estimate is 376.73M CAD.
What is the expected long term growth rate for Nuvei Corporation (NVEI.CA)?
The expected long term growth rate for Nuvei Corporation (NVEI.CA) is 16.28%.